In this study, RARRES1 was found to be highly expressed in epithelial cells (CSCs) and fibroblasts, and studies have revealed the possibility that RARRES1 can be used as a carcinoma-associated fibroblast (CAF) marker gene in breast cancer and may lead to chemotherapy resistance [59, 60]. The gene discussed is RARRES1; the disease is breast carcinoma.